Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 30.34x is 107% above its 5-year average of 14.63x, around the middle of its 5-year range (5.42x–85.01x).
117.62% above its 12-month average of 13.94x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 18.04x.
INTEREST COVERAGE RATIO
30.34x
INTEREST COVERAGE RATIO AVG TTM
13.94x
INTEREST COVERAGE RATIO AVG 3Y
23.30x
INTEREST COVERAGE RATIO AVG 5Y
14.63x
INTEREST COVERAGE RATIO AVG 10Y
17.23x
INTEREST COVERAGE RATIO AVG 15Y
17.72x
INTEREST COVERAGE RATIO AVG 20Y
17.46x
CURRENT VS TTM AVG
+117.62%
CURRENT VS 3Y AVG
+30.20%
CURRENT VS 5Y AVG
+107.38%
CURRENT VS 10Y AVG
+76.14%
CURRENT VS 15Y AVG
+71.21%
CURRENT VS 20Y AVG
+73.81%
SECTOR MEDIAN · HEALTHCARE
6.88x
median of 82 covered companies
CURRENT VS SECTOR MEDIAN
+340.67%
vs the sector median at left
Novo Nordisk A/S
Market Cap
$185.31B
Interest Coverage Ratio
30.34x
TTM Avg
13.94x
3Y Avg
23.30x
5Y Avg
14.63x
Market Cap
$183.17B
Interest Coverage Ratio
11.43x
TTM Avg
6.56x
3Y Avg
7.26x
5Y Avg
7.18x
Market Cap
$177.12B
Interest Coverage Ratio
23.60x
TTM Avg
17.46x
3Y Avg
17.67x
5Y Avg
16.77x
Market Cap
$203.12B
Interest Coverage Ratio
3.88x
TTM Avg
3.09x
3Y Avg
3.93x
5Y Avg
4.89x
Market Cap
$156.76B
Interest Coverage Ratio
5.78x
TTM Avg
5.55x
3Y Avg
10.96x
5Y Avg
11.04x
Market Cap
$146.50B
Interest Coverage Ratio
19.38x
TTM Avg
19.02x
3Y Avg
23.18x
5Y Avg
23.65x
Market Cap
$135.17B
Interest Coverage Ratio
N/A
TTM Avg
55.58x
3Y Avg
55.58x
5Y Avg
55.58x
Market Cap
$130.48B
Interest Coverage Ratio
357.95x
TTM Avg
357.95x
3Y Avg
174.48x
5Y Avg
123.56x
Market Cap
$129.92B
Interest Coverage Ratio
7.26x
TTM Avg
6.11x
3Y Avg
6.76x
5Y Avg
6.22x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novo Nordisk A/S (NVO) | $185.31B | 30.34x | 13.94x | 23.30x | 14.63x |
| Gilead Sciences, Inc. (GILD)vs › | $183.17B | 11.43x | 6.56x | 7.26x | 7.18x |
| Abbott Laboratories (ABT)vs › | $177.12B | 23.60x | 17.46x | 17.67x | 16.77x |
| Amgen Inc. (AMGN)vs › | $203.12B | 3.88x | 3.09x | 3.93x | 4.89x |
| Pfizer Inc. (PFE)vs › | $156.76B | 5.78x | 5.55x | 10.96x | 11.04x |
| Danaher Corporation (DHR)vs › | $146.50B | 19.38x | 19.02x | 23.18x | 23.65x |
| Intuitive Surgical, Inc. (ISRG)vs › | $135.17B | N/A | 55.58x | 55.58x | 55.58x |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.48B | 357.95x | 357.95x | 174.48x | 123.56x |
| Bristol-Myers Squibb Company (BMY)vs › | $129.92B | 7.26x | 6.11x | 6.76x | 6.22x |
| Thermo Fisher Scientific Inc. (TMO)vs › | $241.81B | 5.71x | 5.17x | 6.77x | 10.10x |
Interest Coverage
30.3x
Debt/Equity
0.63
Current Ratio
0.87
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 18.04x |
| 2026-03-31 | 17.04x |
| 2025-06-30 | 6.75x |
| 2025-03-31 | 7.48x |
| 2024-12-31 | 7.21x |
| 2024-09-30 | 41.20x |
| 2024-06-30 | 16.60x |
| 2024-03-31 | 15.35x |
| 2023-12-31 | 29.22x |
| 2023-09-30 | 12.41x |
| 2023-06-30 | 85.01x |
| 2023-03-31 | 22.29x |
| 2022-12-31 | 23.39x |
| 2022-09-30 | 5.42x |
| 2022-06-30 | 5.66x |
| 2022-03-31 | 13.32x |
| 2021-12-31 | 17.45x |
| 2021-09-30 | 16.45x |
| 2021-03-31 | 18.80x |
| 2020-09-30 | 45.91x |
| 2020-06-30 | 26.66x |
| 2020-03-31 | 12.56x |
| 2019-09-30 | 15.58x |
| 2019-06-30 | 10.18x |
| 2019-03-31 | 13.82x |
| 2018-09-30 | 17.50x |
| 2018-06-30 | 16.38x |
| 2018-03-31 | 336.43x |
| 2017-09-30 | 463.23x |
| 2017-06-30 | 11.50x |
| 2017-03-31 | 18.13x |
| 2016-09-30 | 104.37x |
| 2016-06-30 | 1041.42x |
| 2016-03-31 | 32.48x |
| 2015-09-30 | 6.47x |
| 2015-06-30 | 6.45x |
| 2015-03-31 | 8.36x |
| 2014-09-30 | 19.43x |
| 2014-06-30 | 62.38x |
| 2014-03-31 | 25.26x |
| 2013-09-30 | 72.00x |
| 2013-06-30 | 32.15x |
| 2013-03-31 | 70.02x |
| 2012-09-30 | 15.57x |
| 2012-06-30 | 8.94x |
| 2012-03-31 | 17.03x |
| 2011-12-31 | 22.36x |
| 2011-09-30 | 18.21x |
| 2011-06-30 | 31.53x |
| 2011-03-31 | 25.56x |
| 2010-12-31 | 5.36x |
| 2010-09-30 | 10.74x |
| 2010-06-30 | 8.77x |
| 2010-03-31 | 22.47x |
| 2009-12-31 | 11.37x |
| 2009-09-30 | 18.25x |
| 2009-06-30 | 11.33x |
| 2009-03-31 | 9.25x |
| 2008-09-30 | 50.36x |
| 2008-03-31 | 7.69x |
